| UniProt ID | RL14_HUMAN | |
|---|---|---|
| UniProt AC | P50914 | |
| Protein Name | 60S ribosomal protein L14 | |
| Gene Name | RPL14 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 215 | |
| Subcellular Localization | ||
| Protein Description | Component of the large ribosomal subunit.. | |
| Protein Sequence | MVFRRFVEVGRVAYVSFGPHAGKLVAIVDVIDQNRALVDGPCTQVRRQAMPFKCMQLTDFILKFPHSAHQKYVRQAWQKADINTKWAATRWAKKIEARERKAKMTDFDRFKVMKAKKMRNRIIKNEVKKLQKAALLKASPKKAPGTKGTAAAAAAAAAAKVPAKKITAASKKAPAQKVPAQKATGQKAAPAPKAQKGQKAPAQKAPAPKASGKKA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 14 | Phosphorylation | VEVGRVAYVSFGPHA EEECCEEEEEECCCC | 8.18 | 22210691 | |
| 16 | Phosphorylation | VGRVAYVSFGPHAGK ECCEEEEEECCCCCE | 16.29 | 22210691 | |
| 23 | Acetylation | SFGPHAGKLVAIVDV EECCCCCEEEEEEEE | 40.34 | 26051181 | |
| 23 | Ubiquitination | SFGPHAGKLVAIVDV EECCCCCEEEEEEEE | 40.34 | 16196087 | |
| 42 | S-nitrosocysteine | RALVDGPCTQVRRQA CCCCCCCCHHHHHHH | 5.20 | - | |
| 42 | S-nitrosylation | RALVDGPCTQVRRQA CCCCCCCCHHHHHHH | 5.20 | 19483679 | |
| 43 | Phosphorylation | ALVDGPCTQVRRQAM CCCCCCCHHHHHHHC | 32.98 | 24719451 | |
| 46 | Methylation | DGPCTQVRRQAMPFK CCCCHHHHHHHCCCH | 18.38 | 115491719 | |
| 53 | Methylation | RRQAMPFKCMQLTDF HHHHCCCHHHHHHHH | 23.95 | 115976883 | |
| 53 | Ubiquitination | RRQAMPFKCMQLTDF HHHHCCCHHHHHHHH | 23.95 | 23000965 | |
| 53 | Acetylation | RRQAMPFKCMQLTDF HHHHCCCHHHHHHHH | 23.95 | 26051181 | |
| 54 | S-nitrosocysteine | RQAMPFKCMQLTDFI HHHCCCHHHHHHHHH | 1.83 | - | |
| 54 | Glutathionylation | RQAMPFKCMQLTDFI HHHCCCHHHHHHHHH | 1.83 | 22555962 | |
| 54 | S-nitrosylation | RQAMPFKCMQLTDFI HHHCCCHHHHHHHHH | 1.83 | 19483679 | |
| 63 | Acetylation | QLTDFILKFPHSAHQ HHHHHHHHCCCHHHH | 52.62 | 26051181 | |
| 63 | Ubiquitination | QLTDFILKFPHSAHQ HHHHHHHHCCCHHHH | 52.62 | 23000965 | |
| 71 | Acetylation | FPHSAHQKYVRQAWQ CCCHHHHHHHHHHHH | 35.53 | 25825284 | |
| 71 | Ubiquitination | FPHSAHQKYVRQAWQ CCCHHHHHHHHHHHH | 35.53 | 23000965 | |
| 79 | Ubiquitination | YVRQAWQKADINTKW HHHHHHHHCCCCHHH | 37.01 | 23000965 | |
| 79 | Sumoylation | YVRQAWQKADINTKW HHHHHHHHCCCCHHH | 37.01 | 19608861 | |
| 79 | Acetylation | YVRQAWQKADINTKW HHHHHHHHCCCCHHH | 37.01 | 19608861 | |
| 79 | Sumoylation | YVRQAWQKADINTKW HHHHHHHHCCCCHHH | 37.01 | - | |
| 85 | Succinylation | QKADINTKWAATRWA HHCCCCHHHHHHHHH | 30.28 | - | |
| 85 | 2-Hydroxyisobutyrylation | QKADINTKWAATRWA HHCCCCHHHHHHHHH | 30.28 | - | |
| 85 | Succinylation | QKADINTKWAATRWA HHCCCCHHHHHHHHH | 30.28 | 19608861 | |
| 85 | Acetylation | QKADINTKWAATRWA HHCCCCHHHHHHHHH | 30.28 | 19608861 | |
| 85 | Ubiquitination | QKADINTKWAATRWA HHCCCCHHHHHHHHH | 30.28 | 23000965 | |
| 101 | 2-Hydroxyisobutyrylation | KIEARERKAKMTDFD HHHHHHHHHCCCCHH | 47.83 | - | |
| 101 | Ubiquitination | KIEARERKAKMTDFD HHHHHHHHHCCCCHH | 47.83 | 22817900 | |
| 103 | 2-Hydroxyisobutyrylation | EARERKAKMTDFDRF HHHHHHHCCCCHHHH | 45.42 | - | |
| 103 | Acetylation | EARERKAKMTDFDRF HHHHHHHCCCCHHHH | 45.42 | 25953088 | |
| 103 | Ubiquitination | EARERKAKMTDFDRF HHHHHHHCCCCHHHH | 45.42 | 21906983 | |
| 104 | Sulfoxidation | ARERKAKMTDFDRFK HHHHHHCCCCHHHHH | 5.33 | 28183972 | |
| 111 | Ubiquitination | MTDFDRFKVMKAKKM CCCHHHHHHHHHHHH | 42.17 | 24816145 | |
| 116 | Ubiquitination | RFKVMKAKKMRNRII HHHHHHHHHHHHHHH | 41.40 | 24816145 | |
| 124 | 2-Hydroxyisobutyrylation | KMRNRIIKNEVKKLQ HHHHHHHHHHHHHHH | 44.69 | - | |
| 124 | Sumoylation | KMRNRIIKNEVKKLQ HHHHHHHHHHHHHHH | 44.69 | 28112733 | |
| 124 | Ubiquitination | KMRNRIIKNEVKKLQ HHHHHHHHHHHHHHH | 44.69 | 22817900 | |
| 124 | Sumoylation | KMRNRIIKNEVKKLQ HHHHHHHHHHHHHHH | 44.69 | - | |
| 128 | Ubiquitination | RIIKNEVKKLQKAAL HHHHHHHHHHHHHHH | 41.40 | 22817900 | |
| 129 | Ubiquitination | IIKNEVKKLQKAALL HHHHHHHHHHHHHHH | 62.42 | 21963094 | |
| 132 | Ubiquitination | NEVKKLQKAALLKAS HHHHHHHHHHHHHHC | 46.17 | 21963094 | |
| 132 | Acetylation | NEVKKLQKAALLKAS HHHHHHHHHHHHHHC | 46.17 | 27452117 | |
| 137 | Sumoylation | LQKAALLKASPKKAP HHHHHHHHHCCCCCC | 47.90 | - | |
| 137 | Ubiquitination | LQKAALLKASPKKAP HHHHHHHHHCCCCCC | 47.90 | 27667366 | |
| 137 | Malonylation | LQKAALLKASPKKAP HHHHHHHHHCCCCCC | 47.90 | 26320211 | |
| 137 | Sumoylation | LQKAALLKASPKKAP HHHHHHHHHCCCCCC | 47.90 | - | |
| 137 | Acetylation | LQKAALLKASPKKAP HHHHHHHHHCCCCCC | 47.90 | 25953088 | |
| 137 | 2-Hydroxyisobutyrylation | LQKAALLKASPKKAP HHHHHHHHHCCCCCC | 47.90 | - | |
| 139 | Phosphorylation | KAALLKASPKKAPGT HHHHHHHCCCCCCCC | 35.35 | 29255136 | |
| 141 | Ubiquitination | ALLKASPKKAPGTKG HHHHHCCCCCCCCHH | 60.10 | 23000965 | |
| 142 | Ubiquitination | LLKASPKKAPGTKGT HHHHCCCCCCCCHHH | 64.30 | 23000965 | |
| 146 | Phosphorylation | SPKKAPGTKGTAAAA CCCCCCCCHHHHHHH | 25.82 | - | |
| 147 | Ubiquitination | PKKAPGTKGTAAAAA CCCCCCCHHHHHHHH | 61.24 | 23000965 | |
| 149 | Phosphorylation | KAPGTKGTAAAAAAA CCCCCHHHHHHHHHH | 18.06 | 29396449 | |
| 160 | Ubiquitination | AAAAAAAKVPAKKIT HHHHHHHCCCHHHCC | 43.98 | 23000965 | |
| 164 | Ubiquitination | AAAKVPAKKITAASK HHHCCCHHHCCHHHC | 38.34 | 23000965 | |
| 164 | Acetylation | AAAKVPAKKITAASK HHHCCCHHHCCHHHC | 38.34 | 26051181 | |
| 165 | Acetylation | AAKVPAKKITAASKK HHCCCHHHCCHHHCC | 47.60 | 26051181 | |
| 165 | Ubiquitination | AAKVPAKKITAASKK HHCCCHHHCCHHHCC | 47.60 | 21890473 | |
| 171 | Acetylation | KKITAASKKAPAQKV HHCCHHHCCCCCCCC | 48.50 | 25953088 | |
| 171 | Ubiquitination | KKITAASKKAPAQKV HHCCHHHCCCCCCCC | 48.50 | 33845483 | |
| 172 | Acetylation | KITAASKKAPAQKVP HCCHHHCCCCCCCCC | 58.04 | 26051181 | |
| 177 | Acetylation | SKKAPAQKVPAQKAT HCCCCCCCCCCCHHC | 52.90 | 25953088 | |
| 177 | Ubiquitination | SKKAPAQKVPAQKAT HCCCCCCCCCCCHHC | 52.90 | 29967540 | |
| 182 | Acetylation | AQKVPAQKATGQKAA CCCCCCCHHCCCCCC | 50.45 | 26051181 | |
| 182 | Ubiquitination | AQKVPAQKATGQKAA CCCCCCCHHCCCCCC | 50.45 | 33845483 | |
| 182 | 2-Hydroxyisobutyrylation | AQKVPAQKATGQKAA CCCCCCCHHCCCCCC | 50.45 | - | |
| 187 | Acetylation | AQKATGQKAAPAPKA CCHHCCCCCCCCCCC | 48.11 | 20167786 | |
| 187 | Ubiquitination | AQKATGQKAAPAPKA CCHHCCCCCCCCCCC | 48.11 | 33845483 | |
| 193 | Acetylation | QKAAPAPKAQKGQKA CCCCCCCCCCCCCCC | 66.61 | 20167786 | |
| 196 | Acetylation | APAPKAQKGQKAPAQ CCCCCCCCCCCCCCC | 69.07 | 20167786 | |
| 199 | Acetylation | PKAQKGQKAPAQKAP CCCCCCCCCCCCCCC | 66.07 | 25953088 | |
| 204 | Succinylation | GQKAPAQKAPAPKAS CCCCCCCCCCCCCCC | 59.45 | - | |
| 204 | Acetylation | GQKAPAQKAPAPKAS CCCCCCCCCCCCCCC | 59.45 | 25953088 | |
| 204 | Succinylation | GQKAPAQKAPAPKAS CCCCCCCCCCCCCCC | 59.45 | - | |
| 211 | Phosphorylation | KAPAPKASGKKA--- CCCCCCCCCCCC--- | 58.22 | 30576142 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL14_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL14_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL14_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-71; LYS-79 AND LYS-85, ANDMASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
| "Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline."; Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.; Electrophoresis 28:2027-2034(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-139, AND MASSSPECTROMETRY. | |